(CRD-B) Crawford - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2246331076
CRD-B: Claims Management, Claims Adjusting, Risk Management, Repair Management
Crawford & Company (NYSE:CRD-B) is a global leader in claims management and outsourcing solutions, serving insurance carriers, brokers, and corporations across the United States, United Kingdom, Europe, Canada, Australia, Asia, and Latin America. The company operates through four primary segments: North America Loss Adjusting, International Operations, Broadspire, and Platform Solutions.
The North America Loss Adjusting segment specializes in claims management for property, public liability, automobile liability, and marine insurances, catering to insurance carriers and self-insured entities. The International Operations segment provides similar services globally, with a focus on field investigations and the evaluation of property and casualty claims. The Broadspire segment offers comprehensive claims management services, including workers compensation, liability, property, accident, and health claims, alongside disability and leave management, legal services, and risk management analytics. Additionally, Broadspire delivers medical management, desktop claim adjusting, and loss mitigation services such as medical bill review and vocational rehabilitation.
The Platform Solutions segment provides managed repair and outsourced contractor management services, focusing on natural disasters like hurricanes, floods, and earthquakes, as well as man-made disasters such as oil spills and explosions. This segment also offers outsourced subrogation claims management and recovery services. Founded in 1941, Crawford & Company is headquartered in Atlanta, Georgia, and has established itself as a key player in the insurance services industry, leveraging its expertise to streamline claims processes and enhance operational efficiency for clients worldwide.
Based on
From a
Additional Sources for CRD-B Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CRD-B Stock Overview
Market Cap in USD | 550m |
Sector | Financial Services |
Industry | Insurance Brokers |
GiC Sub-Industry | Life & Health Insurance |
IPO / Inception | 1990-01-12 |
CRD-B Stock Ratings
Growth 5y | 67.4% |
Fundamental | 20.1% |
Dividend | 67.6% |
Rel. Strength | 11.3 |
Analysts | 5/5 |
Fair Price Momentum | 12.35 USD |
Fair Price DCF | 12.04 USD |
CRD-B Dividends
Dividend Yield 12m | 2.53% |
Yield on Cost 5y | 5.68% |
Annual Growth 5y | 10.49% |
Payout Consistency | 82.0% |
CRD-B Growth Ratios
Growth Correlation 3m | -11.1% |
Growth Correlation 12m | 79.6% |
Growth Correlation 5y | 63.3% |
CAGR 5y | 18.28% |
CAGR/Max DD 5y | 0.37 |
Sharpe Ratio 12m | 1.36 |
Alpha | 27.27 |
Beta | 0.667 |
Volatility | 43.44% |
Current Volume | 2.3k |
Average Volume 20d | 5.2k |
As of April 01, 2025, the stock is trading at USD 11.42 with a total of 2,259 shares traded.
Over the past week, the price has changed by +2.33%, over one month by -6.55%, over three months by -1.21% and over the past year by +34.34%.
Neither. Based on ValueRay Fundamental Analyses, Crawford is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 20.07 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CRD-B as of April 2025 is 12.35. This means that CRD-B is currently overvalued and has a potential downside of 8.14%.
Crawford has received a consensus analysts rating of 5.00. Therefor, it is recommend to buy CRD-B.
- Strong Buy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, CRD-B Crawford will be worth about 13.4 in April 2026. The stock is currently trading at 11.42. This means that the stock has a potential upside of +17.43%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 14 | 22.6% |
Analysts Target Price | 13 | 13.8% |
ValueRay Target Price | 13.4 | 17.4% |